CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials

Journal:
The Lancet Oncology
Published:
DOI:
10.1016/s1470-2045(26)00053-7
Affiliations:
17
Authors:
14
Go to article
Institutions Authors Share
Sana'a University, Yemen
1.000000
 0.07
University of Tripoli (UT), Libya
1.000000
 0.07
Libyan International Medical University, Libya
1.000000
 0.07
Örebro University, Sweden
1.000000
 0.07
Benha University, Egypt
1.000000
 0.07
Al-Azhar University, Egypt
1.000000
 0.07
Markey Cancer Center (MCC), United States of America (USA)
1.000000
 0.07
Huntsville Hospital Health System, United States of America (USA)
1.000000
 0.07
Baylor College of Medicine (BCM), United States of America (USA)
1.000000
 0.07
Cairo Cure Oncology Center, Egypt
1.000000
 0.07
Korea University, South Korea
1.000000
 0.07
University of Genova, Italy
0.500000
 0.04
IRCCS Azienda Ospedaliera Universitaria San Martino, Italy
0.500000
 0.04
Azienda Usl di Reggio Emilia - IRCCS, Italy
0.500000
 0.04
University of Modena and Reggio Emilia (UNIMORE), Italy
0.500000
 0.04
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK)
0.500000
 0.04
St James's University Hospital, United Kingdom (UK)
0.500000
 0.04
Interested in Oncology and Carcinogenesis?